Adsol Red Cell Preservation Kit
NDC Package 0942-6507-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Adsol Red Cell Preservation (anticoagulant citrate phosphate dextrose (cpd) and adsol preservation) kits is a human prescription drug. This formulation utilizes a kit delivery system. Marketed by Fenwal, Inc., this product is identified by NDC 0942-6507 and is authorized under FDA application BN811104.

Identification & Billing

NDC Package Code
0942-6507-03
Package Description
1 KIT in 1 KIT * 70 mL in 1 BAG * 110 mL in 1 BAG
Product Code
0942-6507
11-Digit Billing Format
00942650703

Clinical Specifications

Proprietary Name
Adsol Red Cell Preservation
Non-Proprietary Name
Anticoagulant Citrate Phosphate Dextrose (cpd) And Adsol Preservation
Dosage Form
Kit - A packaged collection of related material.

Regulatory & Marketing

Labeler Name
Fenwal, Inc.
Product Type
Human Prescription Drug
FDA Application #
BN811104
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-28-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0942-6507-03 identifies a specific commercial package of 1 kit in 1 kit * 70 ml in 1 bag * 110 ml in 1 bag of Adsol Red Cell Preservation, a human prescription drug labeled by Fenwal, Inc.. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fenwal, Inc. on February 28, 2017. The current certification is valid through December 31, 2026.

How is this Fenwal, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00942650703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0942-6507-03
11-Digit CMS (5-4-2)
00942-6507-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.